NEO
Price
$16.69
Change
-$0.35 (-2.05%)
Updated
Oct 22, 11:15 AM (EDT)
Capitalization
2.19B
6 days until earnings call
Intraday BUY SELL Signals
NNOX
Price
$0.39
Change
+$0.01 (+2.63%)
Updated
Oct 22, 11:14 AM (EDT)
Capitalization
30.25M
28 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NEO vs NNOX

NEO vs NNOX Comparison Chart in %
View a ticker or compare two or three
VS
NEO vs. NNOX commentary
Oct 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEO is a Hold and NNOX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for NEO with price predictions
Oct 21, 2026

Aroon Indicator for NEO shows an upward move is likely

NEO's Aroon Indicator triggered a bullish signal on September 30, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 189 similar instances where the Aroon Indicator showed a similar pattern. In 157 of the 189 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 59 cases where NEO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on NEO as a result. In 68 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

Following a +3.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where NEO advanced for three days, in 215 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

NEO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for NEO moved out of overbought territory on September 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 28 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Moving Average Convergence Divergence Histogram (MACD) for NEO turned negative on September 25, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 38 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.

NEO moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NEO crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 55%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NEO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.786) is normal, around the industry mean (64.450). P/E Ratio (-43.692) is within average values for comparable stocks, (2.086). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (3.189) is also within normal values, averaging (9.775).

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. NEO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 64 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

A.I.Advisor
a Summary for NNOX with price predictions
Oct 21, 2026

Momentum Indicator for NNOX turns negative, indicating new downward trend

NNOX saw its Momentum Indicator move below the 0 level on September 21, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned negative. In 83 of the 92 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for NNOX turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 42 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NNOX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for NNOX entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

Following a +9.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where NNOX advanced for three days, in 199 of 237 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

NNOX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.417) is normal, around the industry mean (2.923). P/E Ratio (-0.224) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (3.266) is also within normal values, averaging (40.124).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. NNOX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NNOX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
NEO vs NNOX: Fundamental Ratings
NEO
NNOX
OUTLOOK RATING
1..100
1058
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9299
PRICE GROWTH RATING
1..100
3795
P/E GROWTH RATING
1..100
648
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (27) in the Medical Or Nursing Services industry is in the same range as NNOX (45) in the null industry. This means that NEO’s stock grew similarly to NNOX’s over the last 12 months.

NEO's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as NNOX (100) in the null industry. This means that NEO’s stock grew similarly to NNOX’s over the last 12 months.

NEO's SMR Rating (92) in the Medical Or Nursing Services industry is in the same range as NNOX (99) in the null industry. This means that NEO’s stock grew similarly to NNOX’s over the last 12 months.

NEO's Price Growth Rating (37) in the Medical Or Nursing Services industry is somewhat better than the same rating for NNOX (95) in the null industry. This means that NEO’s stock grew somewhat faster than NNOX’s over the last 12 months.

NNOX's P/E Growth Rating (8) in the null industry is somewhat better than the same rating for NEO (64) in the Medical Or Nursing Services industry. This means that NNOX’s stock grew somewhat faster than NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEONNOX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 23 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 22, 2026
Stock price -- (NEO: $17.04 vs. NNOX: $0.38)
Brand notoriety: NEO and NNOX are both not notable
NEO represents the Medical Specialties, while NNOX is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: NEO: 57% vs. NNOX: 75%
Market capitalization -- NEO: $2.19B vs. NNOX: $30.25M
NEO [@Medical Specialties] is valued at $2.19B. NNOX’s [@Medical/Nursing Services] market capitalization is $30.25M. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The average market capitalization across the [@Medical Specialties] industry is $20.94B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEO’s FA Score shows that 1 FA rating(s) are green while NNOX’s FA Score has 1 green FA rating(s).

  • NEO’s FA Score: 1 green, 4 red.
  • NNOX’s FA Score: 1 green, 4 red.
According to our system of comparison, NEO is a better buy in the long-term than NNOX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEO’s TA Score shows that 5 TA indicator(s) are bullish while NNOX’s TA Score has 3 bullish TA indicator(s).

  • NEO’s TA Score: 5 bullish, 5 bearish.
  • NNOX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, NEO is a better buy in the short-term than NNOX.

Price Growth

NEO (@Medical Specialties) experienced а +0.95% price change this week, while NNOX (@Medical/Nursing Services) price change was -24.63% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.66%. For the same industry, the average monthly price growth was -7.04%, and the average quarterly price growth was +41.88%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.58%. For the same industry, the average monthly price growth was -10.79%, and the average quarterly price growth was -10.51%.

Reported Earning Dates

NEO is expected to report earnings on Oct 28, 2026.

NNOX is expected to report earnings on Nov 19, 2026.

Industries' Descriptions

@Medical Specialties (-3.66% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (-1.58% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
NEO
Daily Signal:
Gain/Loss:
NNOX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with NTRA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then NTRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
+2.53%
NTRA - NEO
54%
Loosely correlated
+1.84%
ADPT - NEO
52%
Loosely correlated
+3.73%
CSTL - NEO
47%
Loosely correlated
+3.68%
RVTY - NEO
46%
Loosely correlated
+0.38%
SHC - NEO
44%
Loosely correlated
-0.89%
More

NNOX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NNOX has been loosely correlated with RDNT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if NNOX jumps, then RDNT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNOX
1D Price
Change %
NNOX100%
-6.87%
RDNT - NNOX
46%
Loosely correlated
-1.78%
TWST - NNOX
44%
Loosely correlated
+4.51%
SMTI - NNOX
39%
Loosely correlated
-1.12%
AZTA - NNOX
38%
Loosely correlated
+2.88%
NEO - NNOX
37%
Loosely correlated
+2.53%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MIN14.060.04
+0.29%
Aberdeen Intermediate Income Fund
PCHI23.490.05
+0.21%
Polen High Income ETF (PCHI)
SFGV36.140.06
+0.18%
Sequoia Global Value ETF (SFGV)
HONG12.30N/A
N/A
Leverage Shares 2X Long HON Daily ETF (HONG)
RSPR34.15-0.18
-0.52%
Invesco S&P 500 Equal Weight Real Estate ETF (RSPR)